How Will AI Make Healthcare More Proactive?

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

On this episode of I Don’t Care, Host Kevin Stevenson talked with Michael Gorton, CEO, Recuro Health, an integrated digital health solution at the intersection of quality, access, and affordability. Serving employers, providers, and managed care organizations. Gorton is also a Co-Founder of Teladoc, a telehealth company that proved vital and disruptive during the COVID-19 Pandemic. The duo talked about Recuro, Teladoc, and Gorton’s views on the healthcare industry.

“Anybody that knows anything about our healthcare system knows it’s not a healthcare system, it’s a sick care system.” – Michael Gorton

Recuro is currently in heavy acquisition mode, and Gorton plans on it being a disruptive vessel in the healthcare system. The goal is to keep people healthy and not let them get sick, which he says is one of the main issues with the current system. Gorton thinks that it’s crazy that the current model doesn’t have this focus.

“Anybody that knows anything about our healthcare system knows it’s not a healthcare system. It’s a sick care system,” Gorton said. “If you want to understand why costs go up year after year, it’s because we’re not keeping people healthy. We’re letting them get sick and taking care of them when they get sick.”

Recuro Health will also have a focus on behavioral health. They also have an element that focuses on testing. With these new aspects, they will send users a box twice a year to take samples. Samples could be urine, hair, or blood. With this information, they’ll be able to understand a user’s health more accurately.

“As simple as getting in your car and looking at the gauge and saying ‘I need to swing by the gas station and get some gasoline.’ Or, ‘I haven’t changed my oil in 5000 miles. I better do that.’ We’re going to give you the same kind of tool kit,” Gorton said.

Listen to Previous Episodes of I Don’t Care!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More